# SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

> **NCT02543476** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 412 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Head and Neck

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02543476
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-16
- **Primary completion:** 2016-11-14
- **Final completion:** 2016-11-14
- **Target enrollment:** 412 (ACTUAL)
- **Last updated:** 2017-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02543476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02543476, "SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT02543476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*